Investment25 Aug 2025, 02:16 pm
Remedium Lifecare Charts 4X Growth Path with Strategic Focus on 4-Point Strategy
AI Summary
Remedium Lifecare Ltd., a rapidly growing player in the pharmaceutical supply chain and specialty chemicals sector, has unveiled a strategic roadmap focusing on advanced manufacturing, global export expansion, innovation and R&D excellence, and product diversification. The company has reported a significant surge in Profit After Tax (PAT) and EBITDA in Q1 FY26, demonstrating the strength of its business model and operational agility. Remedium Lifecare Ltd. also successfully concluded its oversubscribed Rights Issue, raising ₹147.88 crore.
Key Highlights
- Advanced manufacturing strategy to upgrade existing CDMO facilities and expand capacity
- Global export expansion plan to strengthen international footprint and deepen presence in existing markets
- Innovation and R&D excellence supported by the establishment of a dedicated quality control laboratory and scaled research
- Product diversification aimed at broadening the company’s specialty chemical and pharmaceutical portfolio
- Robust Q1 FY26 performance with a 327% surge in PAT and 508% increase in EBITDA